Drugs that contain Benzoyl Peroxide
1. Epsolay patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9868103 | GALDERMA LABS LP | Metal oxide coating of water insoluble ingredients |
Aug, 2028
(4 years from now) | |
| US9687465 | GALDERMA LABS LP | Compositions for the treatment of rosacea |
Nov, 2032
(8 years from now) | |
| US10933046 | GALDERMA LABS LP | Method for treatment of rosacea in patients aged 65 years and older |
Feb, 2040
(15 years from now) | |
| US11541026 | GALDERMA LABS LP | Method for treatment of rosacea |
Feb, 2040
(15 years from now) | |
| US10945987 | GALDERMA LABS LP | Method for providing early onset of action in the treatment of rosacea |
Feb, 2040
(15 years from now) | |
| US11426378 | GALDERMA LABS LP | Method for long-term treatment of rosacea |
Aug, 2040
(16 years from now) | |
| US11628155 | GALDERMA LABS LP | Method for therapeutic treatment of rosacea |
Dec, 2040
(16 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Apr 22, 2025 |
Market Authorisation Date: 22 April, 2022
Treatment: Topical treatment of inflammatory lesions of rosacea in adults 18 years of age and older; Topical treatment of inflammatory lesions of rosacea in adults 65 years of age and older
Dosage: CREAM;TOPICAL
More Information on Dosage
EPSOLAY family patents
